Besides, NEO212 was capable to down-regulate a series of lysosome related gene expression via hindering the nuclear translocation of TFEB, and in turn block the autophagic flux, implying NEO212 might as a promising therapeutic agent against ovarian cancer. The gene discussed is TFEB; the disease is ovarian cancer.